Close Menu

NEW YORK (GenomeWeb) – Natera's fourth quarter 2016 revenues fell 7 percent compared to the fourth quarter of 2015, the firm reported after the close of the market on Tuesday.

The San Carlos, California-based molecular diagnostics company reported total revenues of $49.3 million for the three months ended Dec. 31, 2016, compared to $52.9 million in Q4 2015. Its Q4 2016 revenue was slightly below the analysts' average estimate of $49.8 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.